✦ LIBER ✦

rPSGL-Ig for Improvement of Early Liver Allograft Function: A Double-Blind, Placebo-Controlled, Single-Center Phase II Study

✍ Scribed by R. W. Busuttil; G. S. Lipshutz; J. W. Kupiec-Weglinski; S. Ponthieux; D. W. Gjertson; C. Cheadle; T. Watkins; E. Ehrlich; E. Katz; E. C. Squiers; H. Rabb; S. Hemmerich

Book ID: 114805899
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 266 KB
Volume: 11
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2011.03441.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

YSPSL (rPSGL-Ig) for improvement of earl

YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study

✍ A. Osama Gaber; Shamkant Mulgaonkar; Barry D. Kahan; E. Steve Woodle; Rita Allow 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB